July 9, 2026 July 9, 2026Categories News StoriesPodcast: ASCO Post includes updated STAMP (EA6174) Merkel cell carcinoma data in its ASCO26 highlights, applauding cooperative groups for their ability to study rare cancers
June 4, 2026 June 4, 2026Categories News StoriesA new exploratory analysis from STAMP (EA6174) on aggressive Merkel cell cancer draws attention at ASCO 2026
February 3, 2026 February 3, 2026Categories News StoriesECOG-ACRIN legacy lung cancer studies E1594 and E5508 cited in ASCO Living Guideline 2026.3.0, therapy for stage 4 NSCLC without driver alterations
November 3, 2025 November 3, 2025Categories News StoriesSTAMP (EA6174), the largest trial of adjuvant pembrolizumab in Merkel cell carcinoma, reports key benefit
October 30, 2025 October 30, 2025Categories News StoriesWATCH: Dr. Janice Mehnert discusses STAMP (EA6174) trial results; adjuvant pembrolizumab in resected Merkel cell carcinoma shows improved distant metastasis-free survival
October 13, 2025 October 13, 2025Categories News StoriesNow Enrolling: STOPGAP II trial opens for patients with stomach cancer
September 19, 2025 September 19, 2025Categories News StoriesNow Enrolling: EAA241 trial opens for patients with newly diagnosed multiple myeloma and kidney failure
September 9, 2025 September 9, 2025Categories News StoriesDr. Suzanne Cole on using real-world data to improve the generalizability of clinical trial results (highlights PrE1702 and EA5182)
September 8, 2025 September 8, 2025Categories News StoriesEA5181 trial finds no survival benefit for concurrent and consolidative durvalumab vs consolidation alone in unresectable non-small cell lung cancer
